• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用捏合法制备的阿昔洛韦与泊洛沙姆F127固体分散体的物理化学表征及溶出度研究

Physicochemical characterization and dissolution studies of acyclovir solid dispersions with Pluronic F127 prepared by the kneading method.

作者信息

Karolewicz Bożena, Nartowski Karol, Pluta Janusz, Górniak Agata

出版信息

Acta Pharm. 2016 Mar;66(1):119-28. doi: 10.1515/acph-2016-0008.

DOI:10.1515/acph-2016-0008
PMID:26959548
Abstract

The dissolution rate of anhydrous acyclovir was improved by the preparation of physical mixtures and solid dispersions with the non-ionic polymer Pluronic F127 using the kneading method at different drug-to-polymer ratios. The obtained physical mixtures and solid dispersions were examined in terms of drug content and possible physical and chemical interactions between the drug and polymer using FTIR spectral studies, differential scanning calorimetry and powder X-ray diffraction analysis. The dissolution rate of acyclovir was determined using the rotating disk method. It was found that the minimal content of the polymer within the mixtures needed to increase the dissolution rate of the drug was 50 %.

摘要

通过采用捏合方法,以不同的药物与聚合物比例制备阿昔洛韦与非离子聚合物泊洛沙姆F127的物理混合物和固体分散体,提高了无水阿昔洛韦的溶出速率。使用傅里叶变换红外光谱研究、差示扫描量热法和粉末X射线衍射分析,对所得物理混合物和固体分散体的药物含量以及药物与聚合物之间可能的物理和化学相互作用进行了检测。采用旋转圆盘法测定阿昔洛韦的溶出速率。结果发现,混合物中提高药物溶出速率所需聚合物的最低含量为50%。

相似文献

1
Physicochemical characterization and dissolution studies of acyclovir solid dispersions with Pluronic F127 prepared by the kneading method.采用捏合法制备的阿昔洛韦与泊洛沙姆F127固体分散体的物理化学表征及溶出度研究
Acta Pharm. 2016 Mar;66(1):119-28. doi: 10.1515/acph-2016-0008.
2
Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.辛伐他汀与普朗尼克F127固体分散体的物理化学及溶出度研究
Pharmazie. 2014 Aug;69(8):589-94.
3
Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.卡马西平-泊洛沙姆固体分散体的溶出速率提高及理化性质表征
Pharm Dev Technol. 2016;21(3):268-76. doi: 10.3109/10837450.2014.996899. Epub 2015 Jan 13.
4
Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.使用嵌段共聚物泊洛沙姆407提高布洛芬溶解度和溶解速率的融合方法
AAPS PharmSciTech. 2016 Dec;17(6):1428-1440. doi: 10.1208/s12249-016-0482-6. Epub 2016 Jan 27.
5
Preparation, characterization and tableting of cilnidipine solid dispersions.西尼地平固体分散体的制备、表征及压片
Pak J Pharm Sci. 2013 May;26(3):629-36.
6
Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.丹参酮 IIA 固体分散体的制备及理化性质研究。
Arch Pharm Res. 2011 Jun;34(6):949-59. doi: 10.1007/s12272-011-0612-3. Epub 2011 Jul 2.
7
Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.蒿甲醚冻干法固体分散体的制备与表征
Biomed Res Int. 2015;2015:109563. doi: 10.1155/2015/109563. Epub 2015 May 17.
8
Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.半结晶聚合物对那格列奈自乳化固体分散体的影响:体内外评价
Drug Dev Ind Pharm. 2018 Jan;44(1):56-65. doi: 10.1080/03639045.2017.1371739. Epub 2017 Sep 11.
9
Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.阿昔洛韦-聚乙二醇6000二元分散体:机理洞察
AAPS PharmSciTech. 2017 Aug;18(6):2085-2094. doi: 10.1208/s12249-016-0686-9. Epub 2016 Dec 21.
10
Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.依折麦布基于表面活性剂的固体分散体的制备及物理化学表征
Pharmazie. 2009 Apr;64(4):227-31.

引用本文的文献

1
Application of cosolvency and cocrystallization approach to enhance acyclovir solubility.采用共溶剂法和共结晶法提高阿昔洛韦的溶解度。
BMC Chem. 2025 Jul 30;19(1):226. doi: 10.1186/s13065-025-01591-2.
2
Palatable Levocetirizine Dihydrochloride Solid Dispersed Fast-Dissolving Films: Formulation and and Characterization.美味盐酸左西替利嗪固体分散速溶膜:配方和特性。
ScientificWorldJournal. 2022 Nov 28;2022:1552602. doi: 10.1155/2022/1552602. eCollection 2022.
3
Preliminary Study for the Preparation of Transmucosal or Transdermal Patches with Acyclovir and Lidocaine.
阿昔洛韦与利多卡因透粘膜或透皮贴剂制备的初步研究
Polymers (Basel). 2021 Oct 19;13(20):3596. doi: 10.3390/polym13203596.
4
Design and Assessment of a Polyurethane Carrier Used for the Transmembrane Transfer of Acyclovir.用于阿昔洛韦跨膜转运的聚氨酯载体的设计与评估
Nanomaterials (Basel). 2020 Dec 28;11(1):51. doi: 10.3390/nano11010051.
5
Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.固体分散体提高难溶性药物溶解度、生物利用度和疗效的潜力:较新技术、现行市售情况和专利。
Drug Deliv. 2020 Nov 9;27(1):1625-1643. doi: 10.1080/10717544.2020.1846638.
6
Polypseudorotaxanes of Pluronic® F127 with Combinations of α- and β-Cyclodextrins for Topical Formulation of Acyclovir.聚氧乙烯聚氧丙烯共聚物F127与α-和β-环糊精组合形成的聚准轮烷用于阿昔洛韦的局部制剂
Nanomaterials (Basel). 2020 Mar 27;10(4):613. doi: 10.3390/nano10040613.
7
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.用于提高难溶性药物溶出度和生物利用度的药物分散技术。
Pharmaceutics. 2018 Jun 23;10(3):74. doi: 10.3390/pharmaceutics10030074.